LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 58.88 | 84.90 | 4400 | 7291 | 0.6034 | 0.8488 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 93.96 | 27.76 | 1244 | 6849 | 0.1816 | 0.6137 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 14.58 | 84.90 | 1082 | 663 | 1.6310 | 1.3586 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 87.13 | 27.76 | 6623 | 6987 | 0.9478 | 0.9866 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 58.88 | 84.90 | 83 | 7291 | 0.0114 | -0.0035 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 39.41 | 27.76 | 1980 | 3105 | 0.6376 | 0.8720 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 14.58 | 84.90 | 4 | 663 | 0.0060 | -0.6430 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 36.01 | 27.76 | 60 | 2662 | 0.0225 | 0.1242 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 62.29 | 84.90 | 68 | 7934 | 0.0086 | -0.0333 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 92.25 | 27.76 | 1214 | 6873 | 0.1766 | 0.6082 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 16.29 | 84.90 | 1123 | 766 | 1.4644 | 1.2553 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 90.55 | 27.76 | 6998 | 6928 | 1.0100 | 1.0025 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 16.29 | 84.90 | 7 | 766 | 0.0091 | -0.5443 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 90.55 | 27.76 | 1261 | 6928 | 0.1820 | 0.6148 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 17.99 | 84.90 | 3 | 898 | 0.0033 | -0.6254 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 39.41 | 27.76 | 84 | 3105 | 0.0270 | 0.1767 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 60.59 | 84.90 | 73 | 7641 | 0.0096 | -0.0230 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 36.01 | 27.76 | 1845 | 2662 | 0.6929 | 0.8916 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 60.59 | 84.90 | 4507 | 7641 | 0.5898 | 0.8438 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 37.71 | 27.76 | 1947 | 2877 | 0.6766 | 0.8866 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 33.32 | 84.90 | 30 | 2722 | 0.0110 | -0.1877 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 37.71 | 27.76 | 74 | 2877 | 0.0257 | 0.1577 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 72.52 | 84.90 | 100 | 9214 | 0.0109 | 0.0245 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 92.25 | 27.76 | 7288 | 6873 | 1.0603 | 1.0148 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 26.51 | 84.90 | 1620 | 1923 | 0.8424 | 0.9252 | MN20160318_Q02 | C14 |